On Monday, Shares of Exelixis, Inc. (NASDAQ:EXEL), gained 3.89% to $2.94.
Exelixis, declared that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will provide an overview of the company at the Bank of America Merrill Lynch 2015 Health Care Conference taking place May 12-14 in Las Vegas, NV. The Exelixis presentation is planned for 12:00 p.m. PDT/3:00 p.m. EDT on Tuesday, May 12, 2015.
Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patients with progressive, metastatic medullary thyroid cancer.
At the end of Monday’s trade, Shares of Tenet Healthcare Corp. (NYSE:THC), jumped 3.80% to $49.49.
Tenet Healthcare, stated Adjusted EBITDA of $529 million for the first quarter of 2015, an enhance of $142 million, or 37 percent, contrast to $387 million in the first quarter of 2014.
Tenet generated same-hospital growth in admissions and adjusted admissions of 4.9 percent and 5.9 percent, respectively, contrast to the first quarter of 2014. Paying admissions raised an even stronger 6.2 percent, reflecting growth in the number of newly insured patients. Surgeries raised 7.1 percent and emergency department visits raised 7.2 percent. The company estimates that about two-thirds of its volume growth in the quarter is related to investments in service line development and targeted capital investment.
Tenet raised outpatient visits by 7.6 percent. About 90 percent of this growth was organic. At the end of the quarter, Tenet operated 215 outpatient facilities, an enhance of 26 facilities over the preceding year; these metrics comprise 44 ambulatory surgery centers and 20 imaging centers that are being contributed into the joint venture with United Surgical Partners.
The company continues to benefit from declines in uninsured and charity volumes. In the six states that expanded Medicaid, same-hospital uninsured plus charity admissions declined by 1,593 admissions, or 49.8 percent, and Medicaid admissions raised by 2,645 admissions, or 9.6 percent. Uninsured plus charity outpatient visits reduced by 7,280 visits, or 13.2 percent, and Medicaid outpatient visits grew by 61,979 visits, or 19.5 percent. The six states are comprised of five states that expanded Medicaid in 2014, counting Arizona, California, Illinois, Massachusetts and Michigan, and Pennsylvania, which expanded Medicaid in 2015.
Counting non-expansion states, same-hospital uninsured plus charity admissions reduced by 1,743 admissions, or 13.9 percent, and Medicaid admissions raised by 4,180 admissions, or 8.0 percent. There was a decline in same-hospital charity and uninsured outpatient visits of 8,760 visits, or 5.3 percent, and an enhance in Medicaid outpatient visits of 78,862 visits, or 15.8 percent.
Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer.
Peabody Energy Corp. (NYSE:BTU), ended its last trade with 3.77% gain, and closed at $4.68.
Peabody Energy Corporation, declared that all 12 members of its board of directors were elected at the company’s annual meeting of shareholders.
The Peabody Energy Board of Directors comprise:
- Gregory H. Boyce, Executive Chairman, Peabody Energy
- Glenn L. Kellow, President and Chief Executive Officer, Peabody Energy
- Robert A. Malone, Lead Independent Director, President and Chief Executive Officer, First Sonora Bancshares
- William A. Coley, former Chief Executive Officer, British Energy Group plc
- William E. James, Managing General Partner, RockPort Capital Partners LLC
- Robert B. Karn III, former Managing Partner, Arthur Andersen LLP
- Henry E. Lentz, former Managing Director, Lazard Freres & Co. LLC
- William C. Rusnack, former President and Chief Executive Officer, Premcor Inc.
- Michael W. Sutherlin, former President and Chief Executive Officer, Joy Global, Inc.
- John F. Turner, former Assistant Secretary of State for the Bureau of Oceans and International Environmental and Scientific Affairs
- Sandra A. Van Trease, Group President, BJC Healthcare
- Heather A. Wilson, President, South Dakota School of Mines and Technology.
Peabody Energy Corporation offers mining of coal. The company operates through Western U.S. Mining, Midwestern U.S. Mining, Australian Mining, Trading and Brokerage, and Corporate and Other segments.
Finally, Sorrento Therapeutics, Inc. (NASDAQ:SRNE), closed at $10.72, with 3.57% gain.
Sorrento Therapeutics, declared positive results from recently analyzed pharmacokinetic (PK) data from its TRIBECA (TRIal establishing BioEquivalence between Cynviloq™ and Albumin-bound paclitaxel) registrational trial. Data analysis suggests that Cynviloq meets the bioequivalence (BE) criteria for both total and unbound paclitaxel. The ongoing safety assessment from treated patients continues to reveal no unpredictable adverse events and the safety data is consistent with the toxicity profile stated in the literature with albumin-bound paclitaxel.
Sorrento Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States, Europe, and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
